Priority 01
Repurposed Drugs for Chronic Conditions
Publishing systematic reviews and evidence syntheses on approved drugs with therapeutic promise for post-acute conditions — and building clinical trial protocols to test them.
- AI-assisted drug candidate identification
Priority 02
Post-Viral Syndromes Biobank
Establishing a curated biological sample and data repository from post-viral syndrome patients — providing the standardised infrastructure that reproducible biomarker research requires.
- Standardised sample collection protocols
- Rich clinical annotation and longitudinal design
Priority 03
Post-Viral Syndromes: Diagnosis and Treatment Guidelines
Developing evidence-based diagnostic criteria and educational resources for post-viral syndromes — giving clinicians a structured framework to identify, classify, and treat affected patients.
- Literature synthesis of proposed clinical features
- Expert consensus process with international clinicians
- Validated symptom and biomarker thresholds
- Educational series on post-viral syndromes and PACVS, building the first accredited course on PACVS